E-ISSN 2534-9821
 

Review Article 


Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review

Nada El Dakroury, Chris Bachtsetzis.

Abstract
Benign Prostatic Hyperplasia (BPH) and Prostate Cancer (PCa) are amongst the most common diseases of the prostate gland men develop, as they grow older. BPH leads to the enlargement of the prostate gland and can have severe urinary symptoms, including kidney and lower urinary tract symptoms (LUTS). On the other hand, PCa is the uncontrolled cell proliferation of the prostate gland that can be fatal in severe stages. Both conditions share many symptoms and show a similar clinical presentation. In addition, large-scale epidemiological studies showed that men with BPH have an increased risk of developing PCa. The diagnostic techniques and protocols for BPH and PCa are similar with regards to the fact that both conditions require the assessment of the prostate-specific antigen (PSA) levels as well as the performance of digital rectal examination (DRE) along with the clinical symptom presented by the patient. Furthermore, PCa requires the continuation with a biopsy of the prostate gland, followed or assisted by magnetic resonance imaging (MRI) in order to deliver an MRI fusion procedure. Nonetheless, there is an underlying question on whether BPH and PCa are related or linked in any way. This narrative literature review is aiming to highlight the similarities, the differences and the potential link between BPH and PCa.

Key words: Prostate gland, Benign Prostatic Hyperplasia, Inflammation, Prostate Cancer, Dihydrotestosterone


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nada El Dakroury
Articles by Chris Bachtsetzis
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Dakroury NE, Bachtsetzis C. Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. Int J Med Rev Case Rep. 2021; 5(6): 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer


Web Style

Dakroury NE, Bachtsetzis C. Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. https://www.mdpub.net/?mno=32738 [Access: December 15, 2023]. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer


AMA (American Medical Association) Style

Dakroury NE, Bachtsetzis C. Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. Int J Med Rev Case Rep. 2021; 5(6): 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



Vancouver/ICMJE Style

Dakroury NE, Bachtsetzis C. Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. Int J Med Rev Case Rep. (2021), [cited December 15, 2023]; 5(6): 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



Harvard Style

Dakroury, N. E. & Bachtsetzis, . C. (2021) Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. Int J Med Rev Case Rep, 5 (6), 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



Turabian Style

Dakroury, Nada El, and Chris Bachtsetzis. 2021. Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. International Journal of Medical Reviews and Case Reports, 5 (6), 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



Chicago Style

Dakroury, Nada El, and Chris Bachtsetzis. "Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review." International Journal of Medical Reviews and Case Reports 5 (2021), 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



MLA (The Modern Language Association) Style

Dakroury, Nada El, and Chris Bachtsetzis. "Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review." International Journal of Medical Reviews and Case Reports 5.6 (2021), 1-8. Print. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer



APA (American Psychological Association) Style

Dakroury, N. E. & Bachtsetzis, . C. (2021) Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review. International Journal of Medical Reviews and Case Reports, 5 (6), 1-8. doi:10.5455/IJMRCR.Benign-prostatic-hyperplasia-cancer